# Novartis Pharmaceuticals Corporation – FDA Inspection, Aug 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/b58d0339-4531-411e-9cc4-b4ca576ddf97
Source feed: FDA_Inspections

> FDA inspection 1215374 of Novartis Pharmaceuticals Corporation, August 21, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 30 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215374
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2023-08-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1328008 - 2026-06-24
- [FDA Inspection 1276202 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/d76eeb82-f498-4fa6-9c50-25c0625a0d59)
- FDA Inspection 1263198 - 2025-03-03
- FDA Inspection 1257911 - 2024-11-19
- [FDA Inspection 1248433 - 2024-08-29](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/ccf044c3-0b3e-481e-97b9-66c1a8ca3e62)

## Related Officers

- [Investigator](https://www.keypedia.com/people/mayar-m-mussa/4f39b1c8-93a6-4bc9-a800-5f802db48be6)
- [Company Rep](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)

Company: https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/aa4c85c1-794a-407a-8eb3-8802c196795b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c